This indicator tracks the initial public offering (IPO) of BlossomHill Therapeutics, Inc. on the NASDAQ Global Select exchange, reflecting capital market expansion and fundraising activity by biopharmaceutical companies. Markets monitor IPO events because they provide insights into investor sentiment, capital market conditions, and the ability of companies in the biotech and pharmaceutical sectors to raise capital.